Highlighting Breast Cancer Advances at IBC East
Leading experts in the breast cancer field highlight the use of CDK4/6 inhibitors, antibody-drug conjugates, and other treatment modalities.
New from #CancerNetwork: Dr. Erika Hamilton of SCRI Oncology Partners shares insights on ADCs, CDK4/6 inhibitors & early breast cancer care from #IBC25.
🎧 Listen: www.cancernetwork.com/view/highlig...
#BreastCancer #Oncology #SCRI
31.07.2025 18:12 — 👍 0 🔁 0 💬 0 📌 0
💡 Why consider a clinical trial during your cancer journey?
✨ Access cutting-edge treatments
✨ Stay close to home
✨ Help shape the future of cancer care
🎥 Watch our latest video to learn more: www.scri.com/patients/
#CancerAwareness #ClinicalTrials #OncologyResearch #SCRI #HopeCloseToHome
30.07.2025 18:50 — 👍 0 🔁 0 💬 0 📌 0
YouTube video by Sarah Cannon Research Institute
How Immunotherapy Is Transforming Cancer Care | Dr. David Spigel on News Channel 5
“Can we use the immune system to fight cancer?” Dr. David Spigel of SCRI Oncology Partners answers on #NewsChannel5.
Immunotherapy is changing lives—and Nashville is leading the charge.
🎥 Watch the segment: youtu.be/n45JFZZIy0Q
#CancerResearch #Immunotherapy #ClinicalTrials #Nashville
11.07.2025 21:01 — 👍 0 🔁 0 💬 0 📌 0
Thank you, #ASCO25!
We’re grateful to our presenters, panelists, and the entire ASCO community for an inspiring week of innovation and collaboration.
Here’s to advancing therapies for patients —together.
Until next year!
#SCRI #CancerResearch #OncologyLeadership #ThankYouASCO
05.06.2025 15:18 — 👍 1 🔁 1 💬 0 📌 0
Dr. Meredith McKean delivers her oral presentation on Novel Targets in #Melanoma Treatment at #ASCO2025
03.06.2025 14:23 — 👍 2 🔁 1 💬 0 📌 0
Dr. Naqash serves as chair in the Oral Abstract Session: Lung Cancer-Non-Small Cell Local-Regional/ Small Cell/ Other Thoracic Cancers session. #ASCO25
02.06.2025 20:09 — 👍 1 🔁 0 💬 0 📌 0
David R. Spigel, MD, FASCO, on NSCLC Treatment Planning: Role of 14-Gene Molecular Assay
New data from the AIM-HIGH trial presented by Dr. David Spigel at #ASCO25 shows a 78% relative reduction in recurrence or death with adjuvant chemo for high-risk early-stage #NSCLC patients, identified via a 14-gene molecular assay. Watch interview here: ascopost.com/videos/2025-...
02.06.2025 15:02 — 👍 2 🔁 0 💬 0 📌 0
🚨 LIVE from #ASCO25 🚨
Dr. Erika Hamilton presents first-in-human data on Emi-Le (B7-H4 ADC) in solid tumors.
🔹 ORR: 31% in B7-H4 high
🔹 ORR: 44% w/ ≤4 prior lines
🔹 ACC-I: 55.6% ORR
Promising activity + tolerability in mBC, OC, EC & ACC-I.
#SCRI #ADC #Oncology #ASCO2025
02.06.2025 13:07 — 👍 2 🔁 1 💬 0 📌 0
We look forward to seeing more of you on day four of the #ASCO25 Annual Meeting. Stop by both #27022 to meet experts from across the network, from 9:45am-2:00pm. #CancerResearch uberflip.scri.com/i/1535506-me...
02.06.2025 12:55 — 👍 0 🔁 0 💬 0 📌 0
Dr. Johnson tackled how community oncology can deliver cutting-edge lung cancer therapies:
🔹 Not all bispecifics need inpatient care
🔹 Tarlatamab = outpatient-friendly
🔹 Innovative care models = better access
#LungCancer #Immunotherapy #SCRI #ASCO25
01.06.2025 18:35 — 👍 0 🔁 0 💬 0 📌 0
🔬 At #ASCO25, Dr. Naqash explored the promise & challenges of bispecific T-cell engagers (BiTEs) in lung cancer & beyond:
✅ Tarlatamab earns FDA nod for SCLC
⚠️ CRS & ICANS toxicity management is key
🎯 DLL3 & other targets may expand BiTE reach
#Immunotherapy #LungCancer #SCRI
01.06.2025 16:38 — 👍 1 🔁 0 💬 0 📌 0
At #ASCO25, Dr. @ErikaHamilton9 presented Phase 3 VERITAC-2 results:
🧬 Vedegestrant (first PROTAC ER degrader) showed:
✅ Significant PFS benefit vs fulvestrant (ESR1m ER+/HER2- ABC)
✅ Favorable safety (<5% AEs led to dose changes)
⏳ OS data maturing
A promising new option!
31.05.2025 21:01 — 👍 4 🔁 2 💬 0 📌 0
Dr. Frangoul and patient, Jimi, take the stage in a powerful #AACR/#ASCO joint session, showcasing both side of what it means to explore real-world gene therapy: successes, challenges & equitable access. #ASCO25
31.05.2025 18:45 — 👍 2 🔁 1 💬 0 📌 0
Dr. Skip Burris, President of #SCRI, takes the stage to honor this year’s Top Donors—recognizing the individuals and organizations driving progress in cancer research and care.
Grateful for those fueling the future of oncology. #ASCO25 #CancerResearch #ASCOOpeningSession
31.05.2025 16:13 — 👍 1 🔁 0 💬 0 📌 0
🚨 LIVE from #ASCO25: Dr. Dax Kurbegov shares promising results on a reflex blood-based #MCED test for people with obesity.
🧬 Fills a critical screening gap
📈 Strong PPV & early-stage sensitivity
🔍 Targets cancers w/ no current screening
✅ Warrants prospective validation
31.05.2025 13:30 — 👍 2 🔁 0 💬 1 📌 0
At #ASCO25 Dr. Fontana presents:
KRAS G12C: From First to Next Gen
• Early trials: safe KRAS G12C + anti-EGFR ± chemo
• No unexpected toxicities
• Promising, but not practice-changing
• FDA-approved:
– Sotorasib + panitumumab
– Adagrasib + cetuximab
#GIcancer #KRASG12C
30.05.2025 22:36 — 👍 1 🔁 0 💬 0 📌 0
At SCRI, we’re dedicated to advancing cancer research for patients. Our team accelerates progress through innovative clinical trials—because today’s research leads to tomorrow’s therapies. Meet us at the #ASCO25 and discover what’s next in oncology.
www.scri.com/asco/
30.05.2025 19:54 — 👍 1 🔁 0 💬 0 📌 0
Sarah Cannon Research Institute to Showcase Cancer Insights at 2025 ASCO® Annual Meeting
We are pleased to announce that SCRI leaders will highlight our latest research insights through more than 155 accepted abstracts and presentations at the 2025 ASCO Annual Meeting. For more information, read the press release: www.scri.com/news/sarah-c...
#ASCO25 #CancerResearch #Oncology #SCRI
29.05.2025 16:01 — 👍 1 🔁 0 💬 0 📌 0
We’re thrilled to announce a strategic alliance with @abbvie.bsky.social to accelerate innovative cancer therapies and enhance clinical trial delivery.
Learn more: www.scri.com/news/sarah-c...
#Oncology #CancerResearch #ClinicalTrials #PharmaNews #HealthcareInnovation #SCRI #AbbVie
28.05.2025 12:03 — 👍 0 🔁 0 💬 0 📌 0
May is Melanoma Awareness Month!
SCRI's Dr. Meredith McKean shares expert insights on uveal melanoma, a rare eye cancer.
Hear about her patient Mike’s journey: www.scri.com/patients/?co...
#UvealMelanoma #MelanomaAwareness #PatientStories #SCRI #CancerResearch
23.05.2025 18:49 — 👍 0 🔁 0 💬 0 📌 0
Sarah Cannon Research Institute Welcomes Hans Lee, MD as Director of Myeloma Research
Dr. Hans Lee to Lead SCRI Myeloma Research and Practice Locally at SCRI Oncology Partners in Nashville
We’re thrilled to welcome Dr. Hans Lee as Director of Myeloma Research at SCRI! 🎉
A global leader in myeloma care, Dr. Lee joins us from MD Anderson and will serve patients in Nashville starting June 1.
#Myeloma #CancerResearch #Oncology #SCRI
🔗 www.scri.com/news/sarah-c...
21.05.2025 14:08 — 👍 1 🔁 0 💬 0 📌 0
SCRI and IQVIA are collaborating to accelerate oncology trials globally. Together, we can eliminate operational hurdles, accelerate data delivery, and expedite the availability of cutting-edge therapies. Learn more: www.scri.com/news/iqvia-a...
#ClinicalTrials #ASCO25
16.05.2025 20:02 — 👍 0 🔁 0 💬 0 📌 0
This #OncologyNursingMonth, we honor our exceptional nurses across SCRI. Your commitment to patient care and your expertise in oncology are truly inspiring. Please take a moment to watch this video where our colleagues share their heartfelt thanks. 💙 #ThankYouNurses #HealthcareHeroes
09.05.2025 16:10 — 👍 0 🔁 0 💬 0 📌 0
SCRI expert, Dr. Stephen Strickland presented interim results for SENTI-202 at #AACR2025. This CAR NK cell therapy shows potential in treating relapsed AML, with several patients achieving complete remission. Read more www.usnews.com/news/health-...
#CancerResearch #CAR_NK_Therapy #AML #USNews
02.05.2025 18:55 — 👍 0 🔁 1 💬 0 📌 0
Ivy's journey from Mississippi to Nashville for her battle with stage IV melanoma is inspiring! Thanks to a clinical trial at SCRI Oncology Partners and Dr. McKean's care, she's now cancer-free. Her story is one of hope, resilience, and the power of medical innovation.
www.scri.com/patients/?co...
28.03.2025 15:54 — 👍 1 🔁 0 💬 0 📌 0
Episode 2: Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
A patient case of a 50-year-old man with hormone-sensitive prostate cancer sparked a debate among oncologists regarding the best course of action.
🎧 Dive into the latest Oncology Decoded podcast! Drs. Manoj Bupathi & Benjamin Garmezy discuss optimizing therapy for mHSPC at the 2025 ASCO Symposium. Explore treatment strategies, imaging, and more with top experts! Listen now: #ProstateCancer #SCRI
www.cancernetwork.com/view/episode...
27.03.2025 18:32 — 👍 0 🔁 0 💬 0 📌 0
SCRI is transforming cancer care through groundbreaking trials at 250 locations in 24 states. Join us in advancing therapies and offering hope.
Watch how we collaborate to make a difference.
#CancerResearch #ClinicalTrials #NewHope #SCRI
scri.com
25.03.2025 15:37 — 👍 0 🔁 0 💬 0 📌 0
